Stay up to date with the latest advancements in medical imaging, radiotherapy, nuclear medicine and clinical oncology. This section highlights recently published research, innovative clinical studies and emerging technologies that are shaping patient care and professional practice. Explore the findings, insights and developments that are driving progress across the imaging and oncology community.
The content on this page is provided by the individuals concerned and does not represent the views or opinions of RAD Magazine.
Optical coherence tomography was noninferior to intravascular ultrasound to guide stenting in patients with left main coronary artery disease, according to results presented in a Hot Line session at ESC Congress 2026.[1] Percutaneous coronary intervention (PCI) with stent implantation is used to treat narrowed coronary arteries. The left main coronary artery supplies most of the blood to […]
Read MoreA new PETMR technique that targets fibroblast activation protein (FAP) overexpressed in endometriosis is more effective at identifying lesions than conventional imaging. According to new research published in the August issue of The Journal of Nuclear Medicine, this approach was particularly effective in regions of the pelvis and abdomen that are typically difficult to image. By […]
Read MoreAI analysis of mammograms could be used to detect different common cardiovascular diseases (CVDs), according to a study that presented at ESC Congress 2026.[1] Presenter, Dr Viana Copeland from Chaim Sheba Medical Center, Tel Aviv University, Ramat Gan, Israel, explained why new detection methods are needed for CVD in women: “Despite being the leading cause of death in […]
Read MoreFour in five patients with early and intermediate-stage rectal cancer could be spared life-changing surgery by giving them a combination of chemotherapy and radiotherapy, a UCL-led trial has found. The STAR-TREC trial (Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early Rectal Cancer) found that chemoradiotherapy, with […]
Read MoreNew research from UCL and UCLH suggests that prostate cancer in some men can be identified from an MRI scan with a very high degree of confidence, potentially reducing the need for a biopsy. Four experienced radiologists, working both individually and as a group, identified a subset of patients in whom they were ‘99 per […]
Read MoreA newly developed radiotheranostic pair, 68Ga/177Lu-NYM096, can identify tumors and effectively deliver targeted radiotherapy to patients with metastatic clear cell renal cell carcinoma (ccRCC). Using a small molecule compound, the new approach helps to mitigate toxicity issues common with treatment, offering a safe and feasible strategy for those with end-stage disease. This research was published in the September issue of […]
Read MoreUntil recently, the thymus was thought to be of little use beyond puberty, but new research has shown that radiation to the organ is associated with worse outcomes in patients being treated for non-small cell lung cancer (NSCLC). In a study published in the cancer journal Annals of Oncology [1], researchers analysed 1,107 patients with NSCLC […]
Read MoreSerac Healthcare, a clinical radiopharmaceutical company developing the molecular imaging agent 99mTc-maraciclatide, and the Nuffield Department of Women’s and Reproductive Health at the University of Oxford have had phase 2 data published from the DETECT (Detecting endometriosis expressed integrins using technetium-99m) imaging study. Published online in The Lancet Obstetrics, Gynaecology & Women’s Health, the study […]
Read More